Early MOtion Total Ankle Artroplasty (EMOTAA)

July 31, 2024 updated by: Antonio Mazzotti, Istituto Ortopedico Rizzoli

Comparison of Clinical and Radiological Results of Patients Undergoing Total Ankle Arthroplasty and Treated With Early Mobilization or With Cast Immobilization

Evaluate the clinical and radiographic results of patients undergoing total ankle arthroplasty and treated in the post-operative period in a randomized manner with early mobilization of the ankle joint or with cast immobilization for 3 weeks

Study Overview

Study Type

Interventional

Enrollment (Estimated)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Italia
      • Bologna, Italia, Italy, 40135
        • Recruiting
        • Istituto Ortopedico Rizzoli
        • Contact:
        • Contact:
          • Phone Number: +39 051 636 6111

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult patients (aged between 18 and 80).
  • Male or female patients;
  • Signature of the informed consent for participation in the study;
  • Patients prepared and motivated to comply with the scheduled follow-up visits and the completion of the study questionnaires

Exclusion Criteria:

  • main diagnosis other than osteoarthritis, history of ankle infection
  • need to carry out surgical interventions associated with total prosthesis ankle (e.g., calcaneal osteotomy, knee lowering osteotomy).

first metatarsal bone, supramalleolar osteotomy, etc.)

  • intraoperative complications (for example a malleolar fracture) which require a different post-operative protocol
  • peripheral vascular disease
  • marked osteoporosis of the ankle and foot
  • osteonecrosis of the talus
  • neurological disorders affecting the lower limb inability to understand study information or respond to questionnaires due to cognitive or linguistic deficits
  • patients who are pregnant or breastfeeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mobilizzazione Precoce
early motion of the ankle
perform flexion-extension exercises of the operated ankle
Active Comparator: Immobilizzazione Con Stivaletto Gessato
standard treatment
perform flexion-extension exercises of the operated ankle

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
AOFAS score
Time Frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
The American Orthopedic Foot and Ankle Society Score is a semi-objective rating scale that evaluates ankle pain, motion and alignment and ranges from 0 to 100 points. 0 worst possible score, 100 best possible score
3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
MOXFQ
Time Frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
The MOXFQ is a 16-item instrument answered on a five-point Likert scale (each item is scored from 0 to 4, with 4 denoting 'most severe'). Scores for each item are summed to form three separate subscales representing underlying domains: walking/standing problems (seven items), foot pain (five items), and issues related to social interaction (four items). Raw scale scores are then each converted to a metric from 0 to 100, where 100 denotes the most severe.
3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
SF-36 Questionnaire o Short Form-36 Health Survey
Time Frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
The 36-Item Short Form Health Survey (SF-36) is a popular questionnaire for measuring the self- erception of quality of life in a given population of interest. Processing the answers of a participant comprises the calculation of 10 scores corresponding to 8 scales measuring several aspects of perceived health and 2 summary components (physical and mental)The scores range from 0 point (best) to 100 (worst).
3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
VAS
Time Frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
A Visual Analogue Scale (VAS) is a pain rating scales and ranges from 0 to 10 points
3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
STTA - Sagittal TibioTalar Angle
Time Frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
In a lateral weight-bearing radiograph, the saggittal Tibio Talar Angle is the angke between the rantomica axis of the tibia and the he longitudinal axis of the talus, this is determined by drawing a line connecting the midpoints of a line bisecting the talar neck and another line bisecting the talar body
3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
Hindfoot Alignment - Saltzman view mesurament
Time Frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
On the saltzman radiologial view is calculated thedistance between the axis of the tibia shaft and the contact point of the heel. Normal values -3 ± 7 mm
3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
Lateral distal tibial angle - LDTA
Time Frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
Lateral distal tibia angle (LDTA) is measured between the mid-diaphyseal line of the tibia and the line parallel to the distal tibial plafond. The lateral distal tibial angle has a norm of 89 degrees ± 3 degrees
3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
Anterior distal tibial angle - ADTA
Time Frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
The ADTA is formed by the mechanical axis of the tibia and the joint orientation line of the ankle in the sagittal plane and measures 80° ± 3° in the normal lower extremity
3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
Tibio-Talar Angle - TTA
Time Frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
The tibiotalar angle is between the anatomic axis of the tibia and the superior articular surface of the talar dome. The mean and standard deviation are: 88.7° ± 5.1°
3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
Center of Rotation of Angulation CORA
Time Frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
The CORA is the intersection of the mid-diaphyseal line and the line starting from the middle of the joint and perpendicular to the abnormal ADTA or LDTA. The CORA can be located at the joint line level (usually due to anatomical joint line malalignment or to ankle degeneration) or proximally (usually due to tibial deformities/fractures).
3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
Gamma Angle
Time Frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
Gamma angle (γ) is formed by intersection of line drawn through long axis of talar component with line drawn from posterior talar component through middle of talar neck.
3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
T-T ratio (Tibio-talar Ratio)
Time Frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
Tibiotalar ratio (TT ratio). A talar reference line is drawn parallel to the floor from the posterior talar point (defined as the intersection between the posterosuperior calcaneal cortex and the posterior subtalar articular surface) to the anterior talar point (vertical projection of the most anterior point of the talus onto the talar reference line). Next, the distal tibial axis is the line drawn between the midpoint of the distal tibial shaft measured 5 and 10 cm above the ankle. This divides the talar reference line into anterior and posterior segments. The TT ratio is the ratio of the length of the posterior segment of the talus (AC) to the longitudinal talar length (AB), expressed as a percentage. Normal value, 27% to 42%
3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 31, 2023

Primary Completion (Estimated)

October 31, 2025

Study Completion (Estimated)

October 31, 2027

Study Registration Dates

First Submitted

July 23, 2024

First Submitted That Met QC Criteria

July 24, 2024

First Posted (Actual)

July 29, 2024

Study Record Updates

Last Update Posted (Actual)

August 2, 2024

Last Update Submitted That Met QC Criteria

July 31, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • EMOTAA

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cartilage Disease

Clinical Trials on early mobilizzation of the ankle

Subscribe